Monash IVF Group Limited

ASX:MVF.AX

0.835 (AUD) • At close May 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

2025 Q22024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q2
Revenue 140.386129.521125.704110.267103.32391.319100.97592.8390.77568.3777.04774.80877.17273.68776.95176.47878.70477.22679.33564.66260.29356.42157.59148.6247.978
Cost of Revenue 92.60887.4887.84477.22872.95265.87269.20164.23662.04749.36252.78546.75549.96642.11748.5839.92346.83439.93647.24137.38934.97231.68532.36435.63418.25
Gross Profit 47.77842.04137.8633.03930.37125.44731.77428.59428.72819.00824.26228.05327.20631.5728.37136.55531.8737.2932.09427.27325.32124.73625.22712.98629.728
Gross Profit Ratio 0.340.3250.3010.30.2940.2790.3150.3080.3160.2780.3150.3750.3530.4280.3690.4780.4050.4830.4050.4220.420.4380.4380.2670.62
Reseach & Development Expenses 0000000000000000000000000
General & Administrative Expenses 7.1466.0616.8775.6475.6425.9316.0424.4193.57433.5722.9583.0592.8762.9482.8442.5112.6372.9552.4972.0491.1553.9154.6799.063
Selling & Marketing Expenses 4.0233.7124.0043.6163.3043.1263.3082.993.3972.5733.1452.3692.621.8372.1962.3122.4061.8722.6622.1722.0432.0091.5221.0490.921
SG&A 11.1699.77317.58614.80513.56813.92812.38712.15210.31310.29111.14612.1145.67911.7815.14411.3284.91710.4685.6173.6945.0673.1645.4375.56311.917
Other Expenses 8.83657.88600000000000000000000000
Operating Expenses 20.00567.65917.58614.80513.56813.92812.38712.15210.31310.29111.14612.11411.85816.9239.98415.288.69314.8299.7359.837.70724.0867.6771.63112.83
Operating Income 27.773-25.61820.27418.23416.80311.51919.38716.44218.4158.71713.11615.93916.80314.77118.38721.38123.23222.92922.44120.19917.69618.39817.5513.78916.898
Operating Income Ratio 0.198-0.1980.1610.1650.1630.1260.1920.1770.2030.1270.170.2130.2180.20.2390.280.2950.2970.2830.3120.2940.3260.3050.2840.352
Total Other Income Expenses Net -3.344-2.783-2.529-3.152-2.046-2.428-2.256-1.4982.581-3.643-2.064-1.913-3.244-1.837-1.716-1.722-1.738-2.289-2.484-2.341-2.385-9.914-13.611-12.992-19.998
Income Before Tax 24.429-28.40117.74515.08214.7579.09117.13114.94420.9965.07411.05214.02613.45912.93416.67119.65921.49420.6419.95715.3915.311-5.8543.9390.797-3.1
Income Before Tax Ratio 0.174-0.2190.1410.1370.1430.10.170.1610.2310.0740.1430.1870.1740.1760.2170.2570.2730.2670.2520.2380.254-0.1040.0680.016-0.065
Income Tax Expense 7.203-9.5724.8653.9563.9172.7584.9624.1366.2991.3842.9823.8563.8223.7074.7175.2836.2515.8745.9484.9984.333.1193.6483.8196.603
Net Income 17.012-19.312.77311.19710.6426.32112.08510.5914.5583.5698.15710.1839.6699.312.05314.37615.24314.76614.00910.39210.981-2.855.431-5.008-9.848
Net Income Ratio 0.121-0.1490.1020.1020.1030.0690.120.1140.160.0520.1060.1360.1250.1260.1570.1880.1940.1910.1770.1610.182-0.0510.094-0.103-0.205
EPS 0.043-0.050.0330.0290.0270.0160.0310.0270.0370.0110.0320.040.0410.040.0510.0610.0650.0630.0590.0450.047-0.0180.06-0.015-0.03
EPS Diluted 0.043-0.050.0330.0290.0270.0160.0310.0270.0370.0110.0320.040.0410.0390.0510.0610.0650.0620.0590.0450.047-0.0180.06-0.015-0.03
EBITDA 39.373-27.87429.96324.16524.31917.91125.24922.55328.73114.61818.6518.49317.97116.26220.78422.9725.2624.5824.50321.63419.32819.37118.98214.37619.699
EBITDA Ratio 0.28-0.2150.2380.2190.2350.1960.250.2430.3170.2140.2420.2470.2330.2210.270.30.3210.3180.3090.3350.3210.3430.330.2960.411